Stockscreener 앱 받기
66.13
7.03%
-5.00
시간 외 거래:
64.76
-1.37
-2.07%
전일 마감가:
$71.13
열려 있는:
$71.4
하루 거래량:
1.05M
Relative Volume:
1.15
시가총액:
$2.38B
수익:
$117.67M
순이익/손실:
$-1.88B
주가수익비율:
-1.0924
EPS:
-60.5369
순현금흐름:
$-621.36M
1주 성능:
+0.89%
1개월 성능:
+86.70%
6개월 성능:
+190.75%
1년 성능:
+407.52%
1일 변동 폭
$65.54
$72.83
1주일 범위
$60.02
$75.53
52주 변동 폭
$12.76
$75.53
Grail Inc Stock (GRAL) Company Profile
명칭
Grail Inc
전화
(833) 694-2553
주소
1525 O'BRIEN DRIVE, MENLO PARK
GRAL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
66.13 | 2.56B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
524.80 | 201.90B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
202.46 | 146.42B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
616.15 | 50.30B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
136.62 | 39.72B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
198.17 | 34.51B | 15.70B | 1.24B | 2.01B | 6.9036 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-21 | 개시 | Canaccord Genuity | Buy |
| 2024-11-27 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-10-17 | 개시 | Guggenheim | Neutral |
Grail Inc 주식(GRAL)의 최신 뉴스
CRCM LP Reduces Stake in GRAIL Inc.: A Strategic Portfolio Adjus - GuruFocus
Why GRAIL Inc. (NL0) stock could rally strongly2025 Investor Takeaways & Real-Time Chart Breakout Alerts - newser.com
Recent Developments Impacting GRAL - timothysykes.com
Do Insider Sales at GRAIL (GRAL) Hint at Shifting Management Confidence Amid Revenue Growth? - simplywall.st
GRAIL (GRAL): Evaluating Valuation After 20% Revenue Growth and Modest Share Price Gains - Yahoo Finance
Liquid Biopsy for Early Cancer Detection and Monitoring - GlobeNewswire
Liquid Biopsy for Early Cancer Detection and Monitoring Market Report 2025-2033, with Profiles of GRAIL, AnchorDx, Burning Rock Biotech, Genecast, Guardant Health, Elypta, Freenome, and Oncimmune - Yahoo Finance
Why GRAIL Inc. (NL0) stock stays on top picksTrade Volume Summary & High Accuracy Trade Signal Alerts - newser.com
Insider Sell: Joshua Ofman Sells 9,692 Shares of GRAIL Inc (GRAL) - GuruFocus
Biotech Breakthrough: GRAIL (GRAL) Stock Surges on New Cancer-Detection Data! - ts2.tech
Grail price target raised to $75 from $43 at Canaccord - TipRanks
How GRAIL Inc. (NL0) stock trades under stagflationEarnings Overview Report & Fast Gaining Stock Strategy Reports - newser.com
Grail Inc stock hits all-time high of 64.0 USD By Investing.com - Investing.com Nigeria
Grail Inc stock hits all-time high of 64.0 USD - Investing.com India
Multi-cancer Detection Tests | MCD | GRAIL Galleri Test - American Cancer Society
GRAIL Inc Signs New Headquarters Lease Agreement - MSN
Making Sense of the Numbers: Interpreting Multi-Cancer Early Detection Test Performance - MarketScreener
GRAIL Inc. (GRAL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Grail: A Speculative Buy (NASDAQ:GRAL) - Seeking Alpha
Will GRAL’s Latest Spike Sustain? - timothysykes.com
GRAIL (NASDAQ:GRAL) Stock Price Up 7.2%Still a Buy? - MarketBeat
Why Is GRAIL Stock Rising? - StocksToTrade
Illumina, Grail Beat Investor Suit Over Doomed Acquisition (2) - Bloomberg Law News
What drives GRAIL Inc NL0 stock priceCovered Call Writing & Hidden Gems with Outstanding Profit Margins - earlytimes.in
The European Commission prohibits and plans to unwind Illumina's acquisition of GRAIL - Norton Rose Fulbright
GRAIL, Inc. (GRAL): A Bull Case Theory - MSN
What drives GRAIL LLC stock priceInsider Buying Signals & Compound Your Gains With Quality Stocks - Early Times
Illumina And Grail Nix Investor Suit Over Failed Deal, For Now - Law360
This Cancer Detection Pioneer Is Worth a Look - Yahoo Finance
Is GRAIL LLC stock attractive after correctionSwing Trade & High Conviction Investment Ideas - newser.com
Will Rising Galleri Adoption Drive Growth For GRAIL Stock? - RTTNews
Dakota Wealth Management Makes New Investment in GRAIL, Inc. $GRAL - MarketBeat
GRAIL to Showcase New Data for Galleri Multicancer Early Detection Test at Key Fall Meetings - Patient Care Online
GRAIL to Present New Galleri® Data From More Than 32,000 Partici - GuruFocus
GRAIL to present first PATHFINDER 2 results at ESMO Congress By Investing.com - Investing.com South Africa
GRAIL to present first PATHFINDER 2 results at ESMO Congress - Investing.com
GRAIL to Present New Galleri® Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Congress 2025 and EDCC - MarketScreener
32,000-Patient Study: GRAIL's Blood Test Doubles Early Cancer Detection Rate in Landmark Research - Stock Titan
GRAIL (NASDAQ:GRAL) Trading 7.2% HigherStill a Buy? - MarketBeat
Will GRAIL's (GRAL) New Sunnyvale HQ Boost Its Competitive Position or Strain Resources? - simplywall.st
Grail rallies 30% in wake of Quest agreement - MSN
GRAIL Gains Momentum Post-IPO Amid Strong Sales, Partnerships, and Executive Share Activity - MSN
Big Money Moves: Is GRAIL LLC affected by consumer sentimentJuly 2025 Pullbacks & Safe Entry Zone Tips - خودرو بانک
Grail Inc (GRAL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Grail Inc 주식 (GRAL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Ofman Joshua J. | President |
Oct 02 '25 |
Sale |
64.00 |
9,692 |
620,312 |
478,182 |
0.17%
2.19%
자본화:
|
볼륨(24시간):